nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Prednisone—hematologic cancer	0.267	1	CpDpCtD
Lidocaine—ABCB1—hematologic cancer	0.0393	1	CbGaD
Lidocaine—CYP2C18—Ifosfamide—hematologic cancer	0.0209	0.0483	CbGbCtD
Lidocaine—CYP2A6—Methoxsalen—hematologic cancer	0.0139	0.0321	CbGbCtD
Lidocaine—CYP1A2—Anagrelide—hematologic cancer	0.0119	0.0275	CbGbCtD
Lidocaine—CYP2B6—Thiotepa—hematologic cancer	0.0116	0.0269	CbGbCtD
Lidocaine—CYP2A6—Ifosfamide—hematologic cancer	0.0102	0.0235	CbGbCtD
Lidocaine—CYP2C9—Bexarotene—hematologic cancer	0.00743	0.0172	CbGbCtD
Lidocaine—ABCB1—Lenalidomide—hematologic cancer	0.00721	0.0166	CbGbCtD
Lidocaine—CYP3A7—Ifosfamide—hematologic cancer	0.00694	0.016	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00694	0.016	CbGbCtD
Lidocaine—CYP2A6—Prednisolone—hematologic cancer	0.00677	0.0156	CbGbCtD
Lidocaine—CYP3A7—Imatinib—hematologic cancer	0.00663	0.0153	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00663	0.0153	CbGbCtD
Lidocaine—CYP2B6—Ifosfamide—hematologic cancer	0.00661	0.0153	CbGbCtD
Lidocaine—CYP2C8—Bortezomib—hematologic cancer	0.00653	0.0151	CbGbCtD
Lidocaine—CYP3A5—Daunorubicin—hematologic cancer	0.00649	0.015	CbGbCtD
Lidocaine—CYP2D6—Lomustine—hematologic cancer	0.00631	0.0146	CbGbCtD
Lidocaine—CYP1A2—Carmustine—hematologic cancer	0.00625	0.0144	CbGbCtD
Lidocaine—CYP2C9—Idarubicin—hematologic cancer	0.00615	0.0142	CbGbCtD
Lidocaine—CYP3A5—Thalidomide—hematologic cancer	0.00591	0.0137	CbGbCtD
Lidocaine—CYP2B6—Nilotinib—hematologic cancer	0.00574	0.0133	CbGbCtD
Lidocaine—CYP3A5—Teniposide—hematologic cancer	0.00564	0.013	CbGbCtD
Lidocaine—CYP2D6—Idarubicin—hematologic cancer	0.00563	0.013	CbGbCtD
Lidocaine—CYP1A2—Methoxsalen—hematologic cancer	0.00531	0.0123	CbGbCtD
Lidocaine—CYP3A5—Ifosfamide—hematologic cancer	0.00521	0.012	CbGbCtD
Lidocaine—CYP1A2—Bortezomib—hematologic cancer	0.00505	0.0117	CbGbCtD
Lidocaine—CYP2C8—Ifosfamide—hematologic cancer	0.00501	0.0116	CbGbCtD
Lidocaine—CYP3A5—Imatinib—hematologic cancer	0.00497	0.0115	CbGbCtD
Lidocaine—CYP1A2—Daunorubicin—hematologic cancer	0.00483	0.0112	CbGbCtD
Lidocaine—CYP2D6—Hydroxyurea—hematologic cancer	0.00478	0.0111	CbGbCtD
Lidocaine—CYP1A2—Alitretinoin—hematologic cancer	0.00473	0.0109	CbGbCtD
Lidocaine—CYP2C9—Bortezomib—hematologic cancer	0.00455	0.0105	CbGbCtD
Lidocaine—CYP1A2—Thalidomide—hematologic cancer	0.0044	0.0102	CbGbCtD
Lidocaine—CYP2C8—Nilotinib—hematologic cancer	0.00434	0.01	CbGbCtD
Lidocaine—CYP3A4—Bexarotene—hematologic cancer	0.00432	0.00998	CbGbCtD
Lidocaine—ABCB1—Daunorubicin—hematologic cancer	0.00423	0.00976	CbGbCtD
Lidocaine—CYP2D6—Bortezomib—hematologic cancer	0.00416	0.00962	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00414	0.00957	CbGbCtD
Lidocaine—CYP3A7—Irinotecan—hematologic cancer	0.00414	0.00957	CbGbCtD
Lidocaine—ABCB1—Alitretinoin—hematologic cancer	0.00414	0.00956	CbGbCtD
Lidocaine—CYP3A4—Lomustine—hematologic cancer	0.00401	0.00927	CbGbCtD
Lidocaine—CYP3A4—Busulfan—hematologic cancer	0.00401	0.00927	CbGbCtD
Lidocaine—CYP3A5—Dasatinib—hematologic cancer	0.00399	0.00923	CbGbCtD
Lidocaine—CYP2A6—Dexamethasone—hematologic cancer	0.00399	0.00921	CbGbCtD
Lidocaine—CYP2C9—Thalidomide—hematologic cancer	0.00397	0.00916	CbGbCtD
Lidocaine—CYP2B6—Irinotecan—hematologic cancer	0.00394	0.00911	CbGbCtD
Lidocaine—CYP1A2—Dacarbazine—hematologic cancer	0.00378	0.00874	CbGbCtD
Lidocaine—CYP2C9—Teniposide—hematologic cancer	0.00378	0.00874	CbGbCtD
Lidocaine—CYP1A2—Imatinib—hematologic cancer	0.0037	0.00855	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00362	0.00836	CbGbCtD
Lidocaine—CYP3A7—Vincristine—hematologic cancer	0.00362	0.00836	CbGbCtD
Lidocaine—CYP3A4—Thiotepa—hematologic cancer	0.00358	0.00827	CbGbCtD
Lidocaine—CYP2C9—Ifosfamide—hematologic cancer	0.00349	0.00806	CbGbCtD
Lidocaine—CYP2C9—Imatinib—hematologic cancer	0.00333	0.0077	CbGbCtD
Lidocaine—ABCB1—Imatinib—hematologic cancer	0.00324	0.00748	CbGbCtD
Lidocaine—CYP2B6—Cisplatin—hematologic cancer	0.00321	0.00743	CbGbCtD
Lidocaine—CYP3A5—Irinotecan—hematologic cancer	0.00311	0.00718	CbGbCtD
Lidocaine—CYP2D6—Imatinib—hematologic cancer	0.00305	0.00704	CbGbCtD
Lidocaine—CYP2C9—Nilotinib—hematologic cancer	0.00303	0.007	CbGbCtD
Lidocaine—CYP1A2—Dasatinib—hematologic cancer	0.00297	0.00687	CbGbCtD
Lidocaine—ABCB1—Nilotinib—hematologic cancer	0.00294	0.00679	CbGbCtD
Lidocaine—ABCB1—Vinorelbine—hematologic cancer	0.00292	0.00674	CbGbCtD
Lidocaine—CYP3A4—Methoxsalen—hematologic cancer	0.00278	0.00643	CbGbCtD
Lidocaine—CYP2D6—Nilotinib—hematologic cancer	0.00277	0.0064	CbGbCtD
Lidocaine—CYP2D6—Vinorelbine—hematologic cancer	0.00275	0.00635	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00273	0.0063	CbGbCtD
Lidocaine—CYP3A7—Dexamethasone—hematologic cancer	0.00273	0.0063	CbGbCtD
Lidocaine—CYP3A5—Vincristine—hematologic cancer	0.00271	0.00627	CbGbCtD
Lidocaine—CYP3A4—Bortezomib—hematologic cancer	0.00265	0.00611	CbGbCtD
Lidocaine—ABCB1—Dasatinib—hematologic cancer	0.0026	0.00601	CbGbCtD
Lidocaine—CYP2B6—Dexamethasone—hematologic cancer	0.0026	0.006	CbGbCtD
Lidocaine—ABCB1—Mitoxantrone—hematologic cancer	0.00257	0.00593	CbGbCtD
Lidocaine—CYP3A4—Daunorubicin—hematologic cancer	0.00253	0.00585	CbGbCtD
Lidocaine—CYP3A5—Etoposide—hematologic cancer	0.00249	0.00575	CbGbCtD
Lidocaine—CYP2C8—Etoposide—hematologic cancer	0.00239	0.00553	CbGbCtD
Lidocaine—ABCB1—Betamethasone—hematologic cancer	0.00229	0.00529	CbGbCtD
Lidocaine—ABCB1—Gemcitabine—hematologic cancer	0.00227	0.00524	CbGbCtD
Lidocaine—ABCB1—Prednisolone—hematologic cancer	0.00226	0.00522	CbGbCtD
Lidocaine—CYP3A4—Cytarabine—hematologic cancer	0.00223	0.00516	CbGbCtD
Lidocaine—CYP3A4—Teniposide—hematologic cancer	0.0022	0.00508	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—hematologic cancer	0.00215	0.00498	CbGbCtD
Lidocaine—ABCB1—Prednisone—hematologic cancer	0.00213	0.00493	CbGbCtD
Lidocaine—CYP3A5—Dexamethasone—hematologic cancer	0.00205	0.00473	CbGbCtD
Lidocaine—CYP3A4—Ifosfamide—hematologic cancer	0.00203	0.00469	CbGbCtD
Lidocaine—ABCB1—Irinotecan—hematologic cancer	0.00202	0.00467	CbGbCtD
Lidocaine—CYP2C8—Dexamethasone—hematologic cancer	0.00197	0.00454	CbGbCtD
Lidocaine—CYP3A4—Imatinib—hematologic cancer	0.00194	0.00448	CbGbCtD
Lidocaine—CYP1A2—Etoposide—hematologic cancer	0.00185	0.00428	CbGbCtD
Lidocaine—CYP3A4—Ruxolitinib—hematologic cancer	0.00183	0.00422	CbGbCtD
Lidocaine—ABCB1—Vinblastine—hematologic cancer	0.0018	0.00415	CbGbCtD
Lidocaine—ABCB1—Vincristine—hematologic cancer	0.00177	0.00408	CbGbCtD
Lidocaine—CYP3A4—Nilotinib—hematologic cancer	0.00176	0.00407	CbGbCtD
Lidocaine—CYP3A4—Vinorelbine—hematologic cancer	0.00175	0.00404	CbGbCtD
Lidocaine—CYP2C9—Cisplatin—hematologic cancer	0.0017	0.00392	CbGbCtD
Lidocaine—CYP2D6—Vinblastine—hematologic cancer	0.00169	0.00391	CbGbCtD
Lidocaine—ABCB1—Cisplatin—hematologic cancer	0.00165	0.00381	CbGbCtD
Lidocaine—ABCB1—Etoposide—hematologic cancer	0.00162	0.00374	CbGbCtD
Lidocaine—CYP3A4—Triamcinolone—hematologic cancer	0.0016	0.00369	CbGbCtD
Lidocaine—CYP3A4—Dasatinib—hematologic cancer	0.00156	0.0036	CbGbCtD
Lidocaine—CYP3A4—Mitoxantrone—hematologic cancer	0.00154	0.00355	CbGbCtD
Lidocaine—CYP2C9—Dexamethasone—hematologic cancer	0.00137	0.00317	CbGbCtD
Lidocaine—CYP3A4—Betamethasone—hematologic cancer	0.00137	0.00317	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—hematologic cancer	0.00135	0.00313	CbGbCtD
Lidocaine—ABCB1—Dexamethasone—hematologic cancer	0.00133	0.00308	CbGbCtD
Lidocaine—CYP3A4—Prednisone—hematologic cancer	0.00128	0.00295	CbGbCtD
Lidocaine—CYP2D6—Dexamethasone—hematologic cancer	0.00125	0.0029	CbGbCtD
Lidocaine—CYP3A4—Irinotecan—hematologic cancer	0.00121	0.0028	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—hematologic cancer	0.0011	0.00255	CbGbCtD
Lidocaine—CYP3A4—Vinblastine—hematologic cancer	0.00108	0.00249	CbGbCtD
Lidocaine—ABCB1—Methotrexate—hematologic cancer	0.00107	0.00247	CbGbCtD
Lidocaine—CYP3A4—Vincristine—hematologic cancer	0.00106	0.00245	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—hematologic cancer	0.00104	0.0024	CbGbCtD
Lidocaine—CYP3A4—Etoposide—hematologic cancer	0.00097	0.00224	CbGbCtD
Lidocaine—SCN2A—hematopoietic system—hematologic cancer	0.000854	0.0463	CbGeAlD
Lidocaine—SCN10A—hematopoietic system—hematologic cancer	0.000824	0.0447	CbGeAlD
Lidocaine—CYP3A4—Dexamethasone—hematologic cancer	0.000798	0.00184	CbGbCtD
Lidocaine—EGFR—lung—hematologic cancer	0.000763	0.0414	CbGeAlD
Lidocaine—EGFR—testis—hematologic cancer	0.00072	0.039	CbGeAlD
Lidocaine—CYP3A4—Doxorubicin—hematologic cancer	0.000662	0.00153	CbGbCtD
Lidocaine—SCN9A—lung—hematologic cancer	0.000628	0.0341	CbGeAlD
Lidocaine—SCN9A—testis—hematologic cancer	0.000593	0.0321	CbGeAlD
Lidocaine—SCN2A—blood—hematologic cancer	0.000566	0.0307	CbGeAlD
Lidocaine—SCN10A—blood—hematologic cancer	0.000546	0.0296	CbGeAlD
Lidocaine—SCN4A—testis—hematologic cancer	0.000529	0.0287	CbGeAlD
Lidocaine—EGFR—lymph node—hematologic cancer	0.000522	0.0283	CbGeAlD
Lidocaine—SCN3A—blood—hematologic cancer	0.000497	0.027	CbGeAlD
Lidocaine—SCN5A—blood—hematologic cancer	0.000496	0.0269	CbGeAlD
Lidocaine—SCN3A—bone marrow—hematologic cancer	0.000481	0.0261	CbGeAlD
Lidocaine—SCN10A—lung—hematologic cancer	0.000478	0.0259	CbGeAlD
Lidocaine—SCN3A—lung—hematologic cancer	0.000436	0.0236	CbGeAlD
Lidocaine—CYP2A6—lung—hematologic cancer	0.000436	0.0236	CbGeAlD
Lidocaine—SCN9A—lymph node—hematologic cancer	0.00043	0.0233	CbGeAlD
Lidocaine—CYP2C8—hematopoietic system—hematologic cancer	0.000421	0.0228	CbGeAlD
Lidocaine—SCN3A—testis—hematologic cancer	0.000411	0.0223	CbGeAlD
Lidocaine—CYP1A2—hematopoietic system—hematologic cancer	0.000394	0.0214	CbGeAlD
Lidocaine—CYP3A5—hematopoietic system—hematologic cancer	0.00038	0.0206	CbGeAlD
Lidocaine—CYP2B6—hematopoietic system—hematologic cancer	0.000378	0.0205	CbGeAlD
Lidocaine—CYP2C9—hematopoietic system—hematologic cancer	0.000374	0.0203	CbGeAlD
Lidocaine—SCN10A—lymph node—hematologic cancer	0.000327	0.0177	CbGeAlD
Lidocaine—SCN3A—lymph node—hematologic cancer	0.000298	0.0162	CbGeAlD
Lidocaine—SLC22A5—blood—hematologic cancer	0.000288	0.0156	CbGeAlD
Lidocaine—CYP2B6—gonad—hematologic cancer	0.000287	0.0156	CbGeAlD
Lidocaine—CYP3A4—hematopoietic system—hematologic cancer	0.000285	0.0155	CbGeAlD
Lidocaine—CYP2D6—hematopoietic system—hematologic cancer	0.000281	0.0152	CbGeAlD
Lidocaine—CYP2C8—blood—hematologic cancer	0.000279	0.0151	CbGeAlD
Lidocaine—CYP1A2—blood—hematologic cancer	0.000261	0.0142	CbGeAlD
Lidocaine—SLC22A5—lung—hematologic cancer	0.000253	0.0137	CbGeAlD
Lidocaine—CYP3A5—blood—hematologic cancer	0.000252	0.0137	CbGeAlD
Lidocaine—CYP2B6—blood—hematologic cancer	0.00025	0.0136	CbGeAlD
Lidocaine—CYP2C9—blood—hematologic cancer	0.000248	0.0134	CbGeAlD
Lidocaine—SLC22A5—testis—hematologic cancer	0.000238	0.0129	CbGeAlD
Lidocaine—CYP2C8—testis—hematologic cancer	0.000231	0.0125	CbGeAlD
Lidocaine—CYP1A2—lung—hematologic cancer	0.000229	0.0124	CbGeAlD
Lidocaine—CYP3A5—lung—hematologic cancer	0.000221	0.012	CbGeAlD
Lidocaine—CYP2B6—lung—hematologic cancer	0.000219	0.0119	CbGeAlD
Lidocaine—CYP2B6—testis—hematologic cancer	0.000207	0.0112	CbGeAlD
Lidocaine—ABCB1—hematopoietic system—hematologic cancer	0.000202	0.0109	CbGeAlD
Lidocaine—CYP3A4—blood—hematologic cancer	0.000189	0.0102	CbGeAlD
Lidocaine—CYP2D6—blood—hematologic cancer	0.000186	0.0101	CbGeAlD
Lidocaine—SLC22A5—lymph node—hematologic cancer	0.000173	0.00937	CbGeAlD
Lidocaine—CYP2D6—testis—hematologic cancer	0.000154	0.00834	CbGeAlD
Lidocaine—ABCB1—gonad—hematologic cancer	0.000154	0.00832	CbGeAlD
Lidocaine—ABCB1—blood—hematologic cancer	0.000134	0.00725	CbGeAlD
Lidocaine—ABCB1—bone marrow—hematologic cancer	0.000129	0.00702	CbGeAlD
Lidocaine—ABCB1—lung—hematologic cancer	0.000117	0.00636	CbGeAlD
Lidocaine—ABCB1—testis—hematologic cancer	0.000111	0.006	CbGeAlD
Lidocaine—ABCB1—lymph node—hematologic cancer	8.02e-05	0.00435	CbGeAlD
Lidocaine—Feeling abnormal—Prednisolone—hematologic cancer	2.27e-05	0.000145	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—hematologic cancer	2.27e-05	0.000145	CcSEcCtD
Lidocaine—Headache—Carmustine—hematologic cancer	2.27e-05	0.000144	CcSEcCtD
Lidocaine—Shock—Dexamethasone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Shock—Betamethasone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Dyspnoea—Triamcinolone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Rash—Alitretinoin—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Nervous system disorder—Dexamethasone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Nervous system disorder—Betamethasone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Agitation—Prednisone—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Dermatitis—Alitretinoin—hematologic cancer	2.26e-05	0.000144	CcSEcCtD
Lidocaine—Vomiting—Ifosfamide—hematologic cancer	2.25e-05	0.000143	CcSEcCtD
Lidocaine—Hypersensitivity—Cisplatin—hematologic cancer	2.25e-05	0.000143	CcSEcCtD
Lidocaine—Bradycardia—Epirubicin—hematologic cancer	2.25e-05	0.000143	CcSEcCtD
Lidocaine—Headache—Alitretinoin—hematologic cancer	2.24e-05	0.000143	CcSEcCtD
Lidocaine—Angioedema—Prednisone—hematologic cancer	2.24e-05	0.000143	CcSEcCtD
Lidocaine—Nausea—Thalidomide—hematologic cancer	2.24e-05	0.000142	CcSEcCtD
Lidocaine—Rash—Ifosfamide—hematologic cancer	2.23e-05	0.000142	CcSEcCtD
Lidocaine—Dermatitis—Ifosfamide—hematologic cancer	2.23e-05	0.000142	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—hematologic cancer	2.23e-05	0.000142	CcSEcCtD
Lidocaine—Hyperhidrosis—Dexamethasone—hematologic cancer	2.22e-05	0.000142	CcSEcCtD
Lidocaine—Hyperhidrosis—Betamethasone—hematologic cancer	2.22e-05	0.000142	CcSEcCtD
Lidocaine—Dizziness—Irinotecan—hematologic cancer	2.22e-05	0.000142	CcSEcCtD
Lidocaine—Urticaria—Etoposide—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Lidocaine—Haemoglobin—Epirubicin—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Lidocaine—Rhinitis—Epirubicin—hematologic cancer	2.21e-05	0.000141	CcSEcCtD
Lidocaine—Haemorrhage—Epirubicin—hematologic cancer	2.21e-05	0.000141	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—hematologic cancer	2.2e-05	0.00014	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—hematologic cancer	2.2e-05	0.00014	CcSEcCtD
Lidocaine—Hypoaesthesia—Epirubicin—hematologic cancer	2.19e-05	0.00014	CcSEcCtD
Lidocaine—Vomiting—Vincristine—hematologic cancer	2.19e-05	0.00014	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—hematologic cancer	2.19e-05	0.00014	CcSEcCtD
Lidocaine—Asthenia—Cisplatin—hematologic cancer	2.19e-05	0.000139	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—hematologic cancer	2.19e-05	0.000139	CcSEcCtD
Lidocaine—Rash—Vincristine—hematologic cancer	2.18e-05	0.000139	CcSEcCtD
Lidocaine—Dermatitis—Vincristine—hematologic cancer	2.17e-05	0.000138	CcSEcCtD
Lidocaine—Pain—Triamcinolone—hematologic cancer	2.17e-05	0.000138	CcSEcCtD
Lidocaine—Headache—Vincristine—hematologic cancer	2.16e-05	0.000138	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—hematologic cancer	2.16e-05	0.000137	CcSEcCtD
Lidocaine—Hypotension—Betamethasone—hematologic cancer	2.15e-05	0.000137	CcSEcCtD
Lidocaine—Hypotension—Dexamethasone—hematologic cancer	2.15e-05	0.000137	CcSEcCtD
Lidocaine—Nausea—Carmustine—hematologic cancer	2.15e-05	0.000137	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—hematologic cancer	2.14e-05	0.000136	CcSEcCtD
Lidocaine—Vomiting—Irinotecan—hematologic cancer	2.14e-05	0.000136	CcSEcCtD
Lidocaine—Vomiting—Mitoxantrone—hematologic cancer	2.14e-05	0.000136	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—hematologic cancer	2.13e-05	0.000136	CcSEcCtD
Lidocaine—Nausea—Alitretinoin—hematologic cancer	2.13e-05	0.000136	CcSEcCtD
Lidocaine—Convulsion—Prednisone—hematologic cancer	2.13e-05	0.000135	CcSEcCtD
Lidocaine—Visual impairment—Epirubicin—hematologic cancer	2.13e-05	0.000135	CcSEcCtD
Lidocaine—Hypertension—Prednisone—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Rash—Mitoxantrone—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Rash—Irinotecan—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Dermatitis—Mitoxantrone—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Dermatitis—Irinotecan—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Chills—Methotrexate—hematologic cancer	2.12e-05	0.000135	CcSEcCtD
Lidocaine—Headache—Mitoxantrone—hematologic cancer	2.11e-05	0.000134	CcSEcCtD
Lidocaine—Headache—Irinotecan—hematologic cancer	2.11e-05	0.000134	CcSEcCtD
Lidocaine—Nausea—Ifosfamide—hematologic cancer	2.1e-05	0.000134	CcSEcCtD
Lidocaine—Feeling abnormal—Triamcinolone—hematologic cancer	2.09e-05	0.000133	CcSEcCtD
Lidocaine—Anxiety—Prednisone—hematologic cancer	2.08e-05	0.000133	CcSEcCtD
Lidocaine—Vomiting—Gemcitabine—hematologic cancer	2.08e-05	0.000133	CcSEcCtD
Lidocaine—Bradycardia—Doxorubicin—hematologic cancer	2.08e-05	0.000132	CcSEcCtD
Lidocaine—Paraesthesia—Dexamethasone—hematologic cancer	2.07e-05	0.000132	CcSEcCtD
Lidocaine—Paraesthesia—Betamethasone—hematologic cancer	2.07e-05	0.000132	CcSEcCtD
Lidocaine—Rash—Gemcitabine—hematologic cancer	2.06e-05	0.000131	CcSEcCtD
Lidocaine—Dermatitis—Gemcitabine—hematologic cancer	2.06e-05	0.000131	CcSEcCtD
Lidocaine—Eye disorder—Epirubicin—hematologic cancer	2.06e-05	0.000131	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—hematologic cancer	2.06e-05	0.000131	CcSEcCtD
Lidocaine—Tinnitus—Epirubicin—hematologic cancer	2.06e-05	0.000131	CcSEcCtD
Lidocaine—Erythema—Methotrexate—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Lidocaine—Headache—Gemcitabine—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Lidocaine—Nausea—Vincristine—hematologic cancer	2.05e-05	0.000131	CcSEcCtD
Lidocaine—Flushing—Epirubicin—hematologic cancer	2.05e-05	0.00013	CcSEcCtD
Lidocaine—Cardiac disorder—Epirubicin—hematologic cancer	2.05e-05	0.00013	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—hematologic cancer	2.05e-05	0.00013	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—hematologic cancer	2.04e-05	0.00013	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—hematologic cancer	2.03e-05	0.000129	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.03e-05	0.000129	CcSEcCtD
Lidocaine—Urticaria—Triamcinolone—hematologic cancer	2.01e-05	0.000128	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—hematologic cancer	2.01e-05	0.000128	CcSEcCtD
Lidocaine—Asthenia—Etoposide—hematologic cancer	2.01e-05	0.000128	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—hematologic cancer	2e-05	0.000128	CcSEcCtD
Lidocaine—Oedema—Prednisone—hematologic cancer	2e-05	0.000128	CcSEcCtD
Lidocaine—Angiopathy—Epirubicin—hematologic cancer	2e-05	0.000127	CcSEcCtD
Lidocaine—Nausea—Mitoxantrone—hematologic cancer	2e-05	0.000127	CcSEcCtD
Lidocaine—Nausea—Irinotecan—hematologic cancer	2e-05	0.000127	CcSEcCtD
Lidocaine—Immune system disorder—Epirubicin—hematologic cancer	1.99e-05	0.000127	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.99e-05	0.000127	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.99e-05	0.000127	CcSEcCtD
Lidocaine—Back pain—Methotrexate—hematologic cancer	1.98e-05	0.000126	CcSEcCtD
Lidocaine—Chills—Epirubicin—hematologic cancer	1.98e-05	0.000126	CcSEcCtD
Lidocaine—Shock—Prednisone—hematologic cancer	1.97e-05	0.000126	CcSEcCtD
Lidocaine—Pain—Dexamethasone—hematologic cancer	1.97e-05	0.000125	CcSEcCtD
Lidocaine—Pain—Betamethasone—hematologic cancer	1.97e-05	0.000125	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—hematologic cancer	1.97e-05	0.000125	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—hematologic cancer	1.97e-05	0.000125	CcSEcCtD
Lidocaine—Nausea—Gemcitabine—hematologic cancer	1.94e-05	0.000124	CcSEcCtD
Lidocaine—Vomiting—Cisplatin—hematologic cancer	1.94e-05	0.000124	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—hematologic cancer	1.94e-05	0.000123	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—hematologic cancer	1.93e-05	0.000123	CcSEcCtD
Lidocaine—Rash—Cisplatin—hematologic cancer	1.92e-05	0.000123	CcSEcCtD
Lidocaine—Dermatitis—Cisplatin—hematologic cancer	1.92e-05	0.000122	CcSEcCtD
Lidocaine—Erythema—Epirubicin—hematologic cancer	1.92e-05	0.000122	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—hematologic cancer	1.91e-05	0.000121	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—hematologic cancer	1.9e-05	0.000121	CcSEcCtD
Lidocaine—Feeling abnormal—Betamethasone—hematologic cancer	1.9e-05	0.000121	CcSEcCtD
Lidocaine—Feeling abnormal—Dexamethasone—hematologic cancer	1.9e-05	0.000121	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—hematologic cancer	1.89e-05	0.000121	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—hematologic cancer	1.89e-05	0.000121	CcSEcCtD
Lidocaine—Tension—Epirubicin—hematologic cancer	1.88e-05	0.00012	CcSEcCtD
Lidocaine—Dysgeusia—Epirubicin—hematologic cancer	1.88e-05	0.00012	CcSEcCtD
Lidocaine—Hypersensitivity—Triamcinolone—hematologic cancer	1.87e-05	0.000119	CcSEcCtD
Lidocaine—Nervousness—Epirubicin—hematologic cancer	1.87e-05	0.000119	CcSEcCtD
Lidocaine—Back pain—Epirubicin—hematologic cancer	1.86e-05	0.000118	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—hematologic cancer	1.85e-05	0.000118	CcSEcCtD
Lidocaine—Dizziness—Etoposide—hematologic cancer	1.85e-05	0.000118	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—hematologic cancer	1.84e-05	0.000117	CcSEcCtD
Lidocaine—Chills—Doxorubicin—hematologic cancer	1.83e-05	0.000117	CcSEcCtD
Lidocaine—Urticaria—Betamethasone—hematologic cancer	1.83e-05	0.000116	CcSEcCtD
Lidocaine—Urticaria—Dexamethasone—hematologic cancer	1.83e-05	0.000116	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—hematologic cancer	1.82e-05	0.000116	CcSEcCtD
Lidocaine—Asthenia—Triamcinolone—hematologic cancer	1.82e-05	0.000116	CcSEcCtD
Lidocaine—Nausea—Cisplatin—hematologic cancer	1.81e-05	0.000115	CcSEcCtD
Lidocaine—Vision blurred—Epirubicin—hematologic cancer	1.81e-05	0.000115	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—hematologic cancer	1.8e-05	0.000115	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—hematologic cancer	1.78e-05	0.000113	CcSEcCtD
Lidocaine—Vomiting—Etoposide—hematologic cancer	1.78e-05	0.000113	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—hematologic cancer	1.78e-05	0.000113	CcSEcCtD
Lidocaine—Agitation—Epirubicin—hematologic cancer	1.76e-05	0.000112	CcSEcCtD
Lidocaine—Rash—Etoposide—hematologic cancer	1.76e-05	0.000112	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—hematologic cancer	1.76e-05	0.000112	CcSEcCtD
Lidocaine—Headache—Etoposide—hematologic cancer	1.75e-05	0.000112	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—hematologic cancer	1.75e-05	0.000111	CcSEcCtD
Lidocaine—Tension—Doxorubicin—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Lidocaine—Rash—Prednisolone—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—hematologic cancer	1.74e-05	0.000111	CcSEcCtD
Lidocaine—Headache—Prednisolone—hematologic cancer	1.73e-05	0.00011	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—hematologic cancer	1.73e-05	0.00011	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—hematologic cancer	1.72e-05	0.000109	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—hematologic cancer	1.69e-05	0.000108	CcSEcCtD
Lidocaine—Loss of consciousness—Epirubicin—hematologic cancer	1.69e-05	0.000108	CcSEcCtD
Lidocaine—Dizziness—Triamcinolone—hematologic cancer	1.68e-05	0.000107	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—hematologic cancer	1.67e-05	0.000107	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—hematologic cancer	1.67e-05	0.000107	CcSEcCtD
Lidocaine—Convulsion—Epirubicin—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Lidocaine—Nausea—Etoposide—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Lidocaine—Hypertension—Epirubicin—hematologic cancer	1.66e-05	0.000106	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—hematologic cancer	1.65e-05	0.000105	CcSEcCtD
Lidocaine—Asthenia—Dexamethasone—hematologic cancer	1.65e-05	0.000105	CcSEcCtD
Lidocaine—Asthenia—Betamethasone—hematologic cancer	1.65e-05	0.000105	CcSEcCtD
Lidocaine—Nervous system disorder—Methotrexate—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Lidocaine—Nausea—Prednisolone—hematologic cancer	1.64e-05	0.000104	CcSEcCtD
Lidocaine—Chest pain—Epirubicin—hematologic cancer	1.63e-05	0.000104	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—hematologic cancer	1.63e-05	0.000104	CcSEcCtD
Lidocaine—Anxiety—Epirubicin—hematologic cancer	1.63e-05	0.000104	CcSEcCtD
Lidocaine—Hyperhidrosis—Methotrexate—hematologic cancer	1.62e-05	0.000103	CcSEcCtD
Lidocaine—Vomiting—Triamcinolone—hematologic cancer	1.61e-05	0.000103	CcSEcCtD
Lidocaine—Rash—Triamcinolone—hematologic cancer	1.6e-05	0.000102	CcSEcCtD
Lidocaine—Dermatitis—Triamcinolone—hematologic cancer	1.6e-05	0.000102	CcSEcCtD
Lidocaine—Urticaria—Prednisone—hematologic cancer	1.59e-05	0.000101	CcSEcCtD
Lidocaine—Headache—Triamcinolone—hematologic cancer	1.59e-05	0.000101	CcSEcCtD
Lidocaine—Confusional state—Epirubicin—hematologic cancer	1.58e-05	0.000101	CcSEcCtD
Lidocaine—Anaphylactic shock—Epirubicin—hematologic cancer	1.57e-05	9.98e-05	CcSEcCtD
Lidocaine—Oedema—Epirubicin—hematologic cancer	1.57e-05	9.98e-05	CcSEcCtD
Lidocaine—Hypotension—Methotrexate—hematologic cancer	1.56e-05	9.97e-05	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—hematologic cancer	1.56e-05	9.95e-05	CcSEcCtD
Lidocaine—Shock—Epirubicin—hematologic cancer	1.54e-05	9.82e-05	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—hematologic cancer	1.54e-05	9.81e-05	CcSEcCtD
Lidocaine—Nervous system disorder—Epirubicin—hematologic cancer	1.54e-05	9.79e-05	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—hematologic cancer	1.53e-05	9.77e-05	CcSEcCtD
Lidocaine—Dizziness—Betamethasone—hematologic cancer	1.52e-05	9.69e-05	CcSEcCtD
Lidocaine—Dizziness—Dexamethasone—hematologic cancer	1.52e-05	9.69e-05	CcSEcCtD
Lidocaine—Hyperhidrosis—Epirubicin—hematologic cancer	1.52e-05	9.65e-05	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—hematologic cancer	1.51e-05	9.63e-05	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—hematologic cancer	1.51e-05	9.6e-05	CcSEcCtD
Lidocaine—Nausea—Triamcinolone—hematologic cancer	1.51e-05	9.59e-05	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—hematologic cancer	1.5e-05	9.58e-05	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—hematologic cancer	1.49e-05	9.51e-05	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—hematologic cancer	1.49e-05	9.48e-05	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—hematologic cancer	1.48e-05	9.4e-05	CcSEcCtD
Lidocaine—Hypotension—Epirubicin—hematologic cancer	1.46e-05	9.33e-05	CcSEcCtD
Lidocaine—Vomiting—Betamethasone—hematologic cancer	1.46e-05	9.32e-05	CcSEcCtD
Lidocaine—Vomiting—Dexamethasone—hematologic cancer	1.46e-05	9.32e-05	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—hematologic cancer	1.46e-05	9.31e-05	CcSEcCtD
Lidocaine—Rash—Dexamethasone—hematologic cancer	1.45e-05	9.24e-05	CcSEcCtD
Lidocaine—Rash—Betamethasone—hematologic cancer	1.45e-05	9.24e-05	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.45e-05	9.24e-05	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—hematologic cancer	1.45e-05	9.24e-05	CcSEcCtD
Lidocaine—Dermatitis—Dexamethasone—hematologic cancer	1.45e-05	9.23e-05	CcSEcCtD
Lidocaine—Dermatitis—Betamethasone—hematologic cancer	1.45e-05	9.23e-05	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.45e-05	9.21e-05	CcSEcCtD
Lidocaine—Headache—Betamethasone—hematologic cancer	1.44e-05	9.18e-05	CcSEcCtD
Lidocaine—Headache—Dexamethasone—hematologic cancer	1.44e-05	9.18e-05	CcSEcCtD
Lidocaine—Asthenia—Prednisone—hematologic cancer	1.44e-05	9.16e-05	CcSEcCtD
Lidocaine—Pain—Methotrexate—hematologic cancer	1.43e-05	9.12e-05	CcSEcCtD
Lidocaine—Shock—Doxorubicin—hematologic cancer	1.43e-05	9.09e-05	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—hematologic cancer	1.42e-05	9.06e-05	CcSEcCtD
Lidocaine—Paraesthesia—Epirubicin—hematologic cancer	1.41e-05	8.96e-05	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.4e-05	8.93e-05	CcSEcCtD
Lidocaine—Dyspnoea—Epirubicin—hematologic cancer	1.4e-05	8.9e-05	CcSEcCtD
Lidocaine—Somnolence—Epirubicin—hematologic cancer	1.39e-05	8.87e-05	CcSEcCtD
Lidocaine—Feeling abnormal—Methotrexate—hematologic cancer	1.38e-05	8.79e-05	CcSEcCtD
Lidocaine—Nausea—Dexamethasone—hematologic cancer	1.37e-05	8.71e-05	CcSEcCtD
Lidocaine—Nausea—Betamethasone—hematologic cancer	1.37e-05	8.71e-05	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—hematologic cancer	1.36e-05	8.63e-05	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.35e-05	8.62e-05	CcSEcCtD
Lidocaine—Pain—Epirubicin—hematologic cancer	1.34e-05	8.54e-05	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—hematologic cancer	1.33e-05	8.47e-05	CcSEcCtD
Lidocaine—Dizziness—Prednisone—hematologic cancer	1.33e-05	8.44e-05	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—hematologic cancer	1.3e-05	8.29e-05	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—hematologic cancer	1.29e-05	8.23e-05	CcSEcCtD
Lidocaine—Feeling abnormal—Epirubicin—hematologic cancer	1.29e-05	8.23e-05	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—hematologic cancer	1.29e-05	8.21e-05	CcSEcCtD
Lidocaine—Vomiting—Prednisone—hematologic cancer	1.27e-05	8.12e-05	CcSEcCtD
Lidocaine—Rash—Prednisone—hematologic cancer	1.26e-05	8.05e-05	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—hematologic cancer	1.26e-05	8.04e-05	CcSEcCtD
Lidocaine—Headache—Prednisone—hematologic cancer	1.26e-05	8e-05	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.25e-05	7.97e-05	CcSEcCtD
Lidocaine—Urticaria—Epirubicin—hematologic cancer	1.25e-05	7.93e-05	CcSEcCtD
Lidocaine—Pain—Doxorubicin—hematologic cancer	1.24e-05	7.9e-05	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—hematologic cancer	1.23e-05	7.86e-05	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—hematologic cancer	1.2e-05	7.65e-05	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—hematologic cancer	1.19e-05	7.61e-05	CcSEcCtD
Lidocaine—Nausea—Prednisone—hematologic cancer	1.19e-05	7.58e-05	CcSEcCtD
Lidocaine—Hypersensitivity—Epirubicin—hematologic cancer	1.15e-05	7.35e-05	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—hematologic cancer	1.15e-05	7.34e-05	CcSEcCtD
Lidocaine—Asthenia—Epirubicin—hematologic cancer	1.12e-05	7.16e-05	CcSEcCtD
Lidocaine—Dizziness—Methotrexate—hematologic cancer	1.11e-05	7.05e-05	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—hematologic cancer	1.07e-05	6.8e-05	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—hematologic cancer	1.06e-05	6.78e-05	CcSEcCtD
Lidocaine—Rash—Methotrexate—hematologic cancer	1.06e-05	6.73e-05	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—hematologic cancer	1.05e-05	6.72e-05	CcSEcCtD
Lidocaine—Headache—Methotrexate—hematologic cancer	1.05e-05	6.68e-05	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—hematologic cancer	1.04e-05	6.63e-05	CcSEcCtD
Lidocaine—Dizziness—Epirubicin—hematologic cancer	1.04e-05	6.6e-05	CcSEcCtD
Lidocaine—Vomiting—Epirubicin—hematologic cancer	9.96e-06	6.35e-05	CcSEcCtD
Lidocaine—Nausea—Methotrexate—hematologic cancer	9.95e-06	6.34e-05	CcSEcCtD
Lidocaine—Rash—Epirubicin—hematologic cancer	9.88e-06	6.29e-05	CcSEcCtD
Lidocaine—Dermatitis—Epirubicin—hematologic cancer	9.87e-06	6.29e-05	CcSEcCtD
Lidocaine—Headache—Epirubicin—hematologic cancer	9.82e-06	6.25e-05	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—hematologic cancer	9.59e-06	6.11e-05	CcSEcCtD
Lidocaine—Nausea—Epirubicin—hematologic cancer	9.31e-06	5.93e-05	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—hematologic cancer	9.22e-06	5.87e-05	CcSEcCtD
Lidocaine—Rash—Doxorubicin—hematologic cancer	9.14e-06	5.82e-05	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—hematologic cancer	9.13e-06	5.82e-05	CcSEcCtD
Lidocaine—Headache—Doxorubicin—hematologic cancer	9.08e-06	5.79e-05	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—hematologic cancer	8.61e-06	5.49e-05	CcSEcCtD
Lidocaine—CYP3A4—Metabolism—TXN—hematologic cancer	1.86e-06	2.19e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—hematologic cancer	1.86e-06	2.19e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYCS—hematologic cancer	1.84e-06	2.17e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.84e-06	2.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK8—hematologic cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CD80—hematologic cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CG—hematologic cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KIT—hematologic cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—hematologic cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CD44—hematologic cancer	1.83e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NQO1—hematologic cancer	1.83e-06	2.16e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.83e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SDC1—hematologic cancer	1.83e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.82e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NQO1—hematologic cancer	1.82e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CD44—hematologic cancer	1.82e-06	2.14e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTPN11—hematologic cancer	1.8e-06	2.12e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.8e-06	2.12e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—EP300—hematologic cancer	1.79e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—hematologic cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—hematologic cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.76e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—hematologic cancer	1.76e-06	2.07e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK3—hematologic cancer	1.76e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.75e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.75e-06	2.06e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CREB1—hematologic cancer	1.75e-06	2.05e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.75e-06	2.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—hematologic cancer	1.74e-06	2.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1A—hematologic cancer	1.74e-06	2.05e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYCS—hematologic cancer	1.74e-06	2.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTEN—hematologic cancer	1.74e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BRAF—hematologic cancer	1.73e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.72e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.72e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYCS—hematologic cancer	1.72e-06	2.02e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—hematologic cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6R—hematologic cancer	1.7e-06	2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.7e-06	2e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.7e-06	2e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CREBBP—hematologic cancer	1.7e-06	2e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.69e-06	1.98e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—hematologic cancer	1.68e-06	1.98e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—hematologic cancer	1.68e-06	1.97e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—hematologic cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.65e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	1.64e-06	1.92e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAP2K1—hematologic cancer	1.62e-06	1.91e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—hematologic cancer	1.62e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—hematologic cancer	1.62e-06	1.9e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CD—hematologic cancer	1.61e-06	1.9e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—hematologic cancer	1.61e-06	1.89e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NUP98—hematologic cancer	1.61e-06	1.89e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK3—hematologic cancer	1.61e-06	1.89e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—hematologic cancer	1.58e-06	1.86e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CD44—hematologic cancer	1.55e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NQO1—hematologic cancer	1.55e-06	1.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—hematologic cancer	1.55e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NUP214—hematologic cancer	1.55e-06	1.82e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—hematologic cancer	1.55e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	1.55e-06	1.82e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGF2—hematologic cancer	1.54e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.54e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.53e-06	1.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3R1—hematologic cancer	1.52e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.52e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTR—hematologic cancer	1.52e-06	1.78e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.52e-06	1.78e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.52e-06	1.78e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.51e-06	1.78e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.5e-06	1.77e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NCOR1—hematologic cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—hematologic cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO2—hematologic cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK3—hematologic cancer	1.48e-06	1.74e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JAK2—hematologic cancer	1.48e-06	1.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYCS—hematologic cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.46e-06	1.72e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—hematologic cancer	1.45e-06	1.71e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MDM2—hematologic cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—hematologic cancer	1.44e-06	1.7e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.44e-06	1.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—hematologic cancer	1.44e-06	1.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—hematologic cancer	1.44e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.44e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—hematologic cancer	1.43e-06	1.68e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	1.43e-06	1.68e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SDC1—hematologic cancer	1.41e-06	1.66e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MTOR—hematologic cancer	1.41e-06	1.65e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CB—hematologic cancer	1.41e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.41e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.41e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.39e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.39e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.39e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.36e-06	1.6e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—hematologic cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—hematologic cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—hematologic cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—hematologic cancer	1.33e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.32e-06	1.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—hematologic cancer	1.32e-06	1.55e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.32e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.31e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—hematologic cancer	1.3e-06	1.53e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.3e-06	1.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—hematologic cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—hematologic cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—hematologic cancer	1.29e-06	1.51e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—hematologic cancer	1.28e-06	1.51e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—hematologic cancer	1.27e-06	1.5e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.27e-06	1.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—hematologic cancer	1.26e-06	1.48e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUN—hematologic cancer	1.26e-06	1.48e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.25e-06	1.47e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.25e-06	1.47e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.24e-06	1.46e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—hematologic cancer	1.23e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.23e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.23e-06	1.44e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—hematologic cancer	1.23e-06	1.44e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—hematologic cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.22e-06	1.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—hematologic cancer	1.22e-06	1.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—hematologic cancer	1.22e-06	1.43e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.2e-06	1.41e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CD44—hematologic cancer	1.2e-06	1.41e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK8—hematologic cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—hematologic cancer	1.19e-06	1.39e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.18e-06	1.39e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—hematologic cancer	1.18e-06	1.38e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—hematologic cancer	1.17e-06	1.38e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—hematologic cancer	1.17e-06	1.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—hematologic cancer	1.16e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.15e-06	1.35e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.13e-06	1.33e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—hematologic cancer	1.13e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.13e-06	1.33e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—hematologic cancer	1.13e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.32e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.12e-06	1.31e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.11e-06	1.3e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—hematologic cancer	1.1e-06	1.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—hematologic cancer	1.1e-06	1.29e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—hematologic cancer	1.09e-06	1.28e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.09e-06	1.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—hematologic cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—hematologic cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—hematologic cancer	1.08e-06	1.27e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.06e-06	1.24e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.05e-06	1.24e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.04e-06	1.23e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK3—hematologic cancer	1.04e-06	1.22e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.03e-06	1.22e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.03e-06	1.21e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—hematologic cancer	1.01e-06	1.19e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—hematologic cancer	1.01e-06	1.18e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1e-06	1.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—hematologic cancer	1e-06	1.18e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—hematologic cancer	9.95e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	9.74e-07	1.15e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CD—hematologic cancer	9.74e-07	1.15e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—hematologic cancer	9.72e-07	1.14e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CREBBP—hematologic cancer	9.68e-07	1.14e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—hematologic cancer	9.61e-07	1.13e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CREBBP—hematologic cancer	9.6e-07	1.13e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	9.49e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—hematologic cancer	9.49e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.47e-07	1.11e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—hematologic cancer	9.33e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.28e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—hematologic cancer	9.27e-07	1.09e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3R1—hematologic cancer	9.2e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.19e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.19e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.18e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	9.1e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—hematologic cancer	9.06e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—hematologic cancer	8.98e-07	1.06e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	8.84e-07	1.04e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	8.7e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.67e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.59e-07	1.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—hematologic cancer	8.57e-07	1.01e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CB—hematologic cancer	8.49e-07	9.98e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—hematologic cancer	8.42e-07	9.9e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—hematologic cancer	8.29e-07	9.75e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.2e-07	9.64e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.12e-07	9.55e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—hematologic cancer	8.03e-07	9.44e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	8e-07	9.41e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—hematologic cancer	7.93e-07	9.33e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.93e-07	9.33e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	7.78e-07	9.14e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—hematologic cancer	7.75e-07	9.12e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—hematologic cancer	7.68e-07	9.03e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—hematologic cancer	7.59e-07	8.93e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.34e-07	8.63e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—hematologic cancer	7.34e-07	8.63e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—hematologic cancer	7.1e-07	8.36e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	7.02e-07	8.25e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—hematologic cancer	7e-07	8.24e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—hematologic cancer	7e-07	8.23e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.91e-07	8.13e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	6.86e-07	8.07e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—hematologic cancer	6.85e-07	8.06e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.83e-07	8.03e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	6.78e-07	7.97e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—hematologic cancer	6.59e-07	7.75e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—hematologic cancer	6.54e-07	7.69e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.33e-07	7.44e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6e-07	7.06e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.94e-07	6.99e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—hematologic cancer	5.92e-07	6.97e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—hematologic cancer	5.86e-07	6.89e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—hematologic cancer	5.73e-07	6.74e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.67e-07	6.66e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—hematologic cancer	5.6e-07	6.59e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—hematologic cancer	5.58e-07	6.57e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.23e-07	6.15e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.18e-07	6.09e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.88e-07	5.74e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—hematologic cancer	4.85e-07	5.71e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.83e-07	5.69e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.52e-07	5.32e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—hematologic cancer	4.31e-07	5.07e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—hematologic cancer	4.23e-07	4.97e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.13e-07	4.86e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.98e-07	4.69e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—hematologic cancer	3.95e-07	4.64e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.37e-07	3.97e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.19e-07	3.75e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.6e-07	3.06e-06	CbGpPWpGaD
